Session

Please see below to view the coverage details for this session entry.

Wednesday, October 24

8:15am

Keynote Session: Imatinib as a Paradigm of Targeted Cancer Therapies
Wednesday October 24, 2012 8:15am - 9:00am
Ballroom (9721 Arboretum Boulevard, Austin, TX 78759)
Speakers

Brian Druker, MD

Director, JELD-WEN Chair of Leukemia Research, Oregon Health & Science University Knight Cancer Institute
Presentations Videos